Rastogi A - Search Results

1

Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm.

Rastogi A, Bhatt N, Rossetti S, Beto J. Rastogi A, et al. J Ren Nutr. 2021 Jan;31(1):21-34. doi: 10.1053/j.jrn.2020.02.003. Epub 2020 May 5. J Ren Nutr. 2021. PMID: 32386937 Free article.

2

Disease management in chronic kidney disease.

Rastogi A, Linden A, Nissenson AR. Rastogi A, et al. Adv Chronic Kidney Dis. 2008 Jan;15(1):19-28. doi: 10.1053/j.ackd.2007.10.011. Adv Chronic Kidney Dis. 2008. PMID: 18155106

3

Renal replacement therapy in the elderly.

Ye X, Rastogi A, Nissenson AR. Ye X, et al. Among authors: rastogi a. Clin Geriatr Med. 2009 Aug;25(3):529-42. doi: 10.1016/j.cger.2009.04.003. Clin Geriatr Med. 2009. PMID: 19765494 Review.

4

Internet-based tools to assess diet and provide feedback in chronic kidney disease stage IV: a pilot study.

Murali S, Arab L, Vargas R, Rastogi A, Ang A, Shetty N. Murali S, et al. Among authors: rastogi a. J Ren Nutr. 2013 Mar;23(2):e33-42. doi: 10.1053/j.jrn.2012.05.001. Epub 2012 Jul 21. J Ren Nutr. 2013. PMID: 22819321

5

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.

Rastogi A. Rastogi A. Ther Adv Cardiovasc Dis. 2013 Dec;7(6):322-42. doi: 10.1177/1753944713513061. Ther Adv Cardiovasc Dis. 2013. PMID: 24327730 Free PMC article. Review.

6

The future of renal replacement therapy.

Rastogi A, Nissenson AR. Rastogi A, et al. Adv Chronic Kidney Dis. 2007 Jul;14(3):249-55. doi: 10.1053/j.ackd.2007.05.001. Adv Chronic Kidney Dis. 2007. PMID: 17603978 Review.

7

Spurious elevation in serum creatinine caused by ingestion of nitromethane: implication for the diagnosis and treatment of methanol intoxication.

Rastogi A, Itagaki B, Bajwa M, Kraut JA. Rastogi A, et al. Am J Kidney Dis. 2008 Jul;52(1):181-7. doi: 10.1053/j.ajkd.2007.12.010. Epub 2008 Mar 4. Am J Kidney Dis. 2008. PMID: 18589218 No abstract available.

8

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.

Floege J, Covic AC, Ketteler M, Rastogi A, Chong EM, Gaillard S, Lisk LJ, Sprague SM; PA21 Study Group. Floege J, et al. Among authors: rastogi a. Kidney Int. 2014 Sep;86(3):638-47. doi: 10.1038/ki.2014.58. Epub 2014 Mar 19. Kidney Int. 2014. PMID: 24646861 Free PMC article. Clinical Trial.

9

New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.

Rastogi A, Arman F, Alipourfetrati S. Rastogi A, et al. Curr Hypertens Rep. 2016 Jul;18(7):55. doi: 10.1007/s11906-016-0663-4. Curr Hypertens Rep. 2016. PMID: 27230070 Review.

10

Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.

Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V, Walpen S, Floege J. Ketteler M, et al. Among authors: rastogi a. Nephrol Dial Transplant. 2019 Jul 1;34(7):1163-1170. doi: 10.1093/ndt/gfy127. Nephrol Dial Transplant. 2019. PMID: 29846719 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,299 results

Search Page